汇宇制药：关于自愿披露公司产品获得境外上市许可的公告

Core Viewpoint - The company Seacross (Europe) Pharma Ltd. and Seacross Pharmaceuticals Ltd., subsidiaries of Huiyu Pharmaceutical, have received marketing authorization for their injectable paclitaxel (albumin-bound) from regulatory authorities in Portugal and the UK [2]. Group 1 - The marketing authorization was granted by the Portuguese Medicines and Health Products Authority and the UK Medicines and Healthcare products Regulatory Agency [2].